Long non‐coding RNA EPB41L4A‐AS2 suppresses progression of ovarian cancer by sequestering microRNA‐103a to upregulate transcription factor RUNX1T1
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long non‐coding RNA EPB41L4A‐AS2 suppresses progression of ovarian cancer by sequestering microRNA‐103a to upregulate transcription factor RUNX1T1
Authors
Keywords
-
Journal
EXPERIMENTAL PHYSIOLOGY
Volume 105, Issue 1, Pages 75-87
Publisher
Wiley
Online
2019-10-24
DOI
10.1113/ep087847
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Landscape of tumor suppressor long noncoding RNAs in breast cancer
- (2019) Boran Pang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1
- (2019) Yu-Gang Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U
- (2018) Xueying Yang et al. CANCER LETTERS
- Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method
- (2018) Teng Huang et al. Journal of Translational Medicine
- miRWalk: An online resource for prediction of microRNA binding sites
- (2018) Carsten Sticht et al. PLoS One
- TRIM52 plays an oncogenic role in ovarian cancer associated with NF-kB pathway
- (2018) Weihong Yang et al. Cell Death & Disease
- An in vitro and in vivo study of the role of long non-coding RNA-HOST2 in the proliferation, migration, and invasion of human glioma cells
- (2018) Qi Wang et al. IUBMB LIFE
- lncRNA profile study reveals the mRNAs and lncRNAs associated with docetaxel resistance in breast cancer cells
- (2018) Peide Huang et al. Scientific Reports
- Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction
- (2017) Michelle R. Jones et al. GYNECOLOGIC ONCOLOGY
- International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
- (2017) S.B. Coburn et al. INTERNATIONAL JOURNAL OF CANCER
- mirDIP 4.1—integrative database of human microRNA target predictions
- (2017) Tomas Tokar et al. NUCLEIC ACIDS RESEARCH
- LncATLAS database for subcellular localization of long noncoding RNAs
- (2017) David Mas-Ponte et al. RNA
- Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues
- (2016) Eliana Bignotti et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP
- (2016) Ruilin Lei et al. OncoTargets and Therapy
- The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors
- (2016) Shouping Xu et al. Oncotarget
- Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue
- (2016) Eun Ji Nam et al. Oncotarget
- HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer
- (2016) Yiqing Chai et al. Cancer Medicine
- Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in bladder carcinoma
- (2016) Zhenyu Zhong et al. Scientific Reports
- Diminution of miR-340-5p levels is responsible for increased expression of ABCB5 in melanoma cells under oxygen-deprived conditions
- (2015) Michal Wozniak et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Principles and standards for reporting animal experiments inThe Journal of PhysiologyandExperimental Physiology
- (2015) David Grundy EXPERIMENTAL PHYSIOLOGY
- microRNA-103a Functions as a Mechanosensitive microRNA to Inhibit Bone Formation Through Targeting Runx2
- (2015) Bin Zuo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial
- (2015) Amit M Oza et al. LANCET ONCOLOGY
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- LncRNA: A link between RNA and cancer
- (2014) Guodong Yang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- jvenn: an interactive Venn diagram viewer
- (2014) Philippe Bardou et al. BMC BIOINFORMATICS
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- MiR-103a-3p targets the 5′ UTR ofGPRC5Ain pancreatic cells
- (2014) Honglei Zhou et al. RNA
- A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells
- (2014) Jie Yao et al. TUMOR BIOLOGY
- DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
- (2013) Maria D. Paraskevopoulou et al. NUCLEIC ACIDS RESEARCH
- Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
- (2012) Casina WS Kan et al. BMC CANCER
- Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor,RunX1T1in ovarian cancer
- (2011) Kun-Tu Yeh et al. Epigenetics
- RUNX1T1
- (2011) Aejaz Nasir et al. PANCREAS
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
- (2009) Samuel C. Mok et al. CANCER CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started